COMMON STOCK PURCHASE WARRANT HEDGEPATH PHARMACEUTICALS, INC.Common Stock Purchase Warrant • February 23rd, 2016 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research
Contract Type FiledFebruary 23rd, 2016 Company IndustryThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on , 2021 (the “Termination Date”) but not thereafter, to subscribe for and purchase from HedgePath Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 23rd, 2016 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Florida
Contract Type FiledFebruary 23rd, 2016 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of , 2016, between HedgePath Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto, whether such purchaser is or becomes a signature as of the Initial Closing or any Subsequent Closing (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).